Anebulo Pharmaceuticals Statistics
Total Valuation
ANEB has a market cap or net worth of $92.85 million. The enterprise value is $82.50 million.
Important Dates
The last earnings date was Thursday, November 13, 2025, after market close.
| Earnings Date | Nov 13, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
ANEB has 41.08 million shares outstanding. The number of shares has increased by 45.22% in one year.
| Current Share Class | 41.08M |
| Shares Outstanding | 41.08M |
| Shares Change (YoY) | +45.22% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 40.54% |
| Owned by Institutions (%) | 2.90% |
| Float | 3.40M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 9.54 |
| P/TBV Ratio | 9.54 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 10.93
| Current Ratio | 10.93 |
| Quick Ratio | 10.75 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -26.70 |
Financial Efficiency
Return on equity (ROE) is -145.11% and return on invested capital (ROIC) is -97.45%.
| Return on Equity (ROE) | -145.11% |
| Return on Assets (ROA) | -86.11% |
| Return on Invested Capital (ROIC) | -97.45% |
| Return on Capital Employed (ROCE) | -93.16% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$2.81M |
| Employee Count | 3 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +45.81% in the last 52 weeks. The beta is -0.87, so ANEB's price volatility has been lower than the market average.
| Beta (5Y) | -0.87 |
| 52-Week Price Change | +45.81% |
| 50-Day Moving Average | 2.46 |
| 200-Day Moving Average | 1.87 |
| Relative Strength Index (RSI) | 39.86 |
| Average Volume (20 Days) | 16,648 |
Short Selling Information
The latest short interest is 116,684, so 0.28% of the outstanding shares have been sold short.
| Short Interest | 116,684 |
| Short Previous Month | 163,504 |
| Short % of Shares Out | 0.28% |
| Short % of Float | 3.43% |
| Short Ratio (days to cover) | 5.32 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -9.07M |
| Pretax Income | -8.44M |
| Net Income | -8.44M |
| EBITDA | n/a |
| EBIT | -9.07M |
| Earnings Per Share (EPS) | -$0.22 |
Full Income StatementBalance Sheet
The company has $10.35 million in cash and n/a in debt, giving a net cash position of $10.35 million or $0.25 per share.
| Cash & Cash Equivalents | 10.35M |
| Total Debt | n/a |
| Net Cash | 10.35M |
| Net Cash Per Share | $0.25 |
| Equity (Book Value) | 9.74M |
| Book Value Per Share | 0.24 |
| Working Capital | 9.57M |
Full Balance SheetCash Flow
| Operating Cash Flow | -5.93M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |